本报告研究涉及企业/品牌/案例：e互助、相互宝。

在国家政策的支持下，中国网络互助行业不断发展，逐渐成为医疗保障的有益补充。2019年中国网络互助行业救助总人数规模超过3万人，行业救助总金额超50亿元。截至2019年年底，中国网络互助覆盖人数达1.5亿人，预计2020年中国网络互助覆盖率达17.8%，2022年网络互助覆盖人数达有望达到3.9亿，覆盖率将达27.8%。通过网络互助平台的对比，结果显示，相较于报销型和综合型平台，给付型和聚焦型平台在人均互助金、获助比例等方面更具优势，e互助综合能力领先各平台。目前没有发现网络互助行业的规模效应，平台会员分摊未来有望保持平稳发展。未来中国网络互助将进入繁荣发展期，有望成为“国民级”产品，专业化运营与风险管控将成平台重点发展方向，行业也将从同质化到募集效率、金额的差异化发展。

With the support of national policies, China's network mutual assistance industry has continued to develop and has gradually become a useful supplement to medical security. In 2019, the total number of people assisted by China's network mutual assistance industry exceeded 30,000, and the total amount of industry assistance exceeded 5 billion yuan. At the end of 2019, the number of people covered by China's network mutual assistance reached 150 million. It is estimated that the coverage rate of China's network mutual assistance will reach 17.8% in 2020, and the number of network mutual assistance coverage is expected to reach 390 million in 2022, with a coverage rate of 27.8%. Through the comparison of network mutual assistance platforms, the results show that, compared with reimbursement and integrated platforms, payment and focused platforms have more advantages in terms of per capita mutual assistance, the proportion of assistance and so on. Besides, the comprehensive ability of “E HUAZHU” leads all platforms. At present, the scale effect of the network mutual assistance industry has not been found, and the platform members are expected to maintain stable spending in the future. In the future, China's network mutual assistance will enter a period of prosperity and development, and it is expected to become a "national-level" product. Professional operation and risk management will become the key development direction of the platforms. The industry will also develop from homogeneity to differentiated development in raising efficiency and amount.

本报告研究涉及企业/品牌/案例：云测数据，龙猫数据。

在政策利好、场景需求剧增和5G落地等因素的推动下，中国AI行业的市场规模不断扩大，核心产业市场规模2020年将达到1500亿元，发展从规范化阶段向专业化阶段迈进，市场前景广阔。艾媒咨询分析师认为，随着技术的成熟、平台的布局，未来市场发展潜力将不断拓展，AI数据服务将被运用在多种实际场景，如医疗、金融、新零售和安防等。随着AI与传统行业的不断融合以及5G的发展，数据类型将会更加多样化，越来越多的企业将会随着场景定制化升级对精准度提出更高的要求，促使AI数据服务方式由粗放式向着精细化方向过渡。AI数据服务产业链的日趋完善促使竞争日趋激烈，因此数据服务的技术升级将成为竞争的焦点，在很大程度上直接影响数据服务商在市场的竞争地位。

Driven by factors such as favorable policies, a sharp increase in demand, and the launch of 5G, the market size of China's AI industry continues to expand. The core industry market size will reach 150 billion yuan in 2020, and development will move from the standardized stage to the professional stage with broad market prospects.iiMedia Consulting analysts believe that with the maturity of the technology and the layout of the platform, the future market development potential will continue to expand. Besides, AI data services will be used in a variety of practical areas, such as medical, financial, new retail and security.With the continuous integration of AI and traditional industries and the development of 5G, data types will become more diversified. In addition, more and more enterprises will put forward higher requirements for accuracy as scenarios are customized and upgraded, prompting AI data service transfer from extensive methods to refined methods.The increasing improvement of the AI data service industry chain has led to increasingly fierce competition. Therefore, the technological upgrading of data services will become the focus of competition, which to a large extent will directly affect the competitive position of data service providers in the market.

本报告研究涉及企业/品牌/案例：老肯医疗，新华医疗，威莱，三友化工；
其他提及企业/品牌：滴露，威露士，蓝月亮，洗得宝，威猛先生，如辉，巨光，海氏海诺，威王，净安，优露清，利尔康，安洁，威洁士，欧洁，仁和，泰和科技，京汉股份，比亚迪，仁瑞生物科技，盘龙药业，东北制药等。

2020年4月28日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年全球消毒杀毒产品市场分析及发展趋势报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对全球消毒杀毒产品进行全面分析，并且通过对三友化工、威莱集团（威尔士）、新华医疗和老肯医疗的典型企业案例分析，特别结合新冠疫情影响下消毒杀毒用品的用户调研，判断2020-2021年全球消毒杀毒行业发展趋势。随着经济环境和人民生活水平不断改善，国家对于医疗卫生更加重视，卫生投入不断增加，医疗机构数量显著增长，居民的卫生健康意识也持续提高，从需求端拉动消毒产品行业发展。特别在新冠疫情影响下，消毒杀毒产品的需求量骤升，其中小包装的消杀产品需求量特别大，短期消杀用品存在供需结构矛盾。

In 2020, the national medical institutions and other public places need large-scale, long-term, high-frequency disinfection, in addition, the public awareness of home disinfection has also given birth to a huge demand for disinfection products. According to iiMedia Research, the new crown outbreak in 2020 has had an impact on the purchase of disinfection products by 84% of consumers, with the market value of disinfection products expected to reach 38.26 billion yuan for the full year.

本报告研究涉及企业/品牌/案例：欣龙控股，振德医疗，奥美医疗，尚荣医疗，际华集团，蓝帆医疗，兵装集团；其他提及企业/品牌：金三发科技，中国石油，赢合科技，鑫台铭，斯凯瑞，CM朝美，华东医药，爱马斯，海王星辰，北京同仁堂，拼多多，天猫，京东，上海通用五菱，比亚迪，龙头股份，华纺股份，水星家纺，红豆股份

2020年4月3日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年中国后疫时代医疗防护行业及细分领域分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对2020年中国医疗防护行业及其细分领域的口罩、防护服、手套、护目镜等进行分析。此外，报告探讨产业上下游的运营模式，结合对欣龙控股、振德医疗、奥美医疗、尚荣医疗、际华集团、蓝帆医疗和兵装集团等典型企业的案例分析，对钢铁行业总体运行情况进行分析，并结合新冠疫情对2020-2021年中国医疗防护产业发展进行趋势预判。相较于发达国家，中国的医疗防护行业起步晚，防护水平低，由于医疗防护用品属于低值耗材，所以国内市场的品牌化理念也不强。但是，随着近些年中国经济的发展，国内的医疗防护市场逐渐升温，新老企业都有了品牌意识。在未来的发展道路上，品牌化和专业化将成为国内医疗防护用品生产企业的核心竞争力。

The outbreak of new crown pneumonia has raised awareness of personal protection, and the market potential for medical protective supplies is huge, and China's demand for medical protective equipment such as masks and gloves is expected to grow rapidly. In addition, the global outbreak of the new crown has also become a great opportunity for the export of China's medical protection products. As the first region to erupt in the outbreak, China has the first advantage of medical protective supplies, and the production capacity of medical protective supplies can be exported overseas.

本报告研究涉及企业/品牌/案例：平安好医生,康爱多,阿里健康,健客,鱼跃医疗；其他提及企业/品牌：益药购,1药网,九州通网,心诺,我的医药网,好药师,美之氧,药京采,七乐康,欧姆龙,普天药城网,氧生活,未名企鹅,爱康多,巨人,药药好,京东大药房,康祝,药品终端网,360好药,可孚,药师帮,药房网,艾润科技,药便宜,八百方

2020年3月9日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020-2021年中国医疗电商行业发展趋势及标杆企业分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对2020年中国医疗电商产业发展进行分析。本报告主要通过医药电商和家用医疗器械两方面，对医疗电商产业上下游深入探究运行模式，并对鱼跃集团、平安好医生、爱康多等典型企业进行案例分析，以此对中国医疗电商行业发展进行趋势预判。2019年中国医药电商行业发展规模继续增大，涌现出许多新型零售方式。越来越多医药企业涌入B2B主流市场，B2C市场规模也随着消费者健康意识的提升以及网购消费习惯的固定而得到较大发展；越来越多药企也开始开展O2O业务。以药到医、“医+药”发展的模式也受到普遍认可。特别在新型冠状病毒肺炎疫情影响下，医疗电商以其独特的互联网优势在抗击疫情中发挥了重要作用。在此契机下，医疗电商行业将在2020年迎来重大普及发展的历史机遇期。

In 2019, the scale of China's pharmaceutical e-commerce industry continues to increase, and many new retail methods have emerged. More and more pharmaceutical companies have entered the mainstream B2B market, and the scale of the B2C market has also grown significantly with the improvement of consumers' health awareness and the fixation of online shopping consumption habits; more and more pharmaceutical companies have begun to develop O2O business. The development model from medicine to medicine and "medicine + medicine" has also been widely recognized. Especially under the influence of the new coronavirus pneumonia epidemic, medical e-commerce has played an important role in fighting the epidemic with its unique Internet advantage. With this opportunity, the medical e-commerce industry will usher in a period of historical opportunities for significant popularization in 2020.

本报告研究涉及企业/品牌包括:Mavidon,Titan Medical,Aspire Capital Fund,CentriMag,汇桥资本集团,联影医疗技术集团,医达极星,大博医疗,安捷伦,润扬医疗器械,迈瑞医疗,乐普医疗,威高医用,华大基因,安图生物,健帆生物,鱼跃医疗,京东方科技,美亚光电,东软集团,祥生医疗,硕世生物,佰仁医疗,爱博诺德,伟思医疗,安必平,林华医疗,拱东医疗,天智航,三友医疗,赛科希德等。

截至 2020 年 1 月 31 日 24:00，国家卫生健康委员会公布全国确诊病例 11791 例，重症病例 1795 例。短期来看，预计疫情将继续持续一段时间。肺炎疫情期间，病毒检测带动试剂盒需求增加；病毒治疗带动医用设备及医用耗材需求增加。部分医疗器械企业有望构成业绩增厚。

As of 24:00 on January 31, 2020, the National Health Commission announced 11791 confirmed cases and 1795 severe cases. In the short term, the outbreak is expected to continue for some time. During the pneumonia epidemic, virus detection drives demand for kits; virus treatment drives demand for medical equipment and supplies. Some medical device companies are expected to increase their performance.

本报告研究涉及企业/品牌/案例：华为，大立科技，云测数据，京东众智，百度数据众包，阿里云，百度智能云，深海科技，商汤，云从科技，依图，阅面科技，出门问问，科大讯飞，云知声，普强信息，阿里巴巴，百度，腾讯，京东，松鼠AI，小i机器人，图灵机器人，海康威视，学堂在线，知鸟，蚂蚁金服，第四范式，京东数科，百度医疗大脑，阿里健康，平安智慧城市，一汽，大众，启辰，东风日产

中国人工智能产业增长快速，预计2030年中国人工智能核心产业规模将突破10000亿元。数据的沉积、算法的优化和算力的提升为人工智能技术的商业化应用奠定了坚实基础。越来越多传统行业借助人工智能技术进行转型升级，并受到大众的广泛关注。iiMedia Research(艾媒咨询)数据显示，人工智能与金融、安防、医疗、教育等领域的融合发展成为大众的重点关注领域，37.8%的受访者表示最了解人工智能在金融领域的应用；39.3%的受访者最期待人工智能在医疗领域的应用；66.8%的受访者对人工智能未来发展表示看好。艾媒咨询分析师认为，随着人工智能领域细分化和专业化程度的不断提升，人工智能商业化进程将会提速，但快速发展携带而来的信息安全风险以及道德伦理问题不容忽视。
China's artificial intelligence industry is growing rapidly. It is expected that the scale of China's artificial intelligence core industry will exceed 100 billion yuan in 2030. The deposition of data, the optimization of algorithms, and the enhancement of computing power have laid a solid foundation for the commercial application of artificial intelligence technology. More and more traditional industries rely on artificial intelligence technology for transformation and upgrading, and they have attracted widespread attention. According to iiMedia Research data, the integrated development of artificial intelligence and finance, security, medical care, education and other fields has become the focus of attention of the public. 37.8% of the respondents said they knew the application of artificial intelligence in the financial field best; 39.3 % Of the respondents are most looking forward to the application of artificial intelligence in the medical field; 66.8% of the respondents are optimistic about the future development of artificial intelligence. iiMedia Consulting analysts believe that with the continuous improvement of the segmentation and specialization of the artificial intelligence field, the commercialization of artificial intelligence will accelerate, but the information security risks and ethical issues brought about by rapid development cannot be ignored.

随着人工智能的不断发展，人工智能产业不断深化，中国人工智能企业数量也在不断上升，但在技术与应用领域，均存在着不同程度的挑战与风险。对于未来人工智能技术的发展，态势虽一路高涨，但仍不能放松警惕。由人工智能带来的新一轮工业革命已经到来，教育呈现出与技术发展的不均衡必将导致失业问题的出现。对于人工智能带来的新的需求，唯有保持学习才能不被技术超前。
With the continuous development of artificial intelligence and the deepening of the artificial intelligence industry, the number of Chinese artificial intelligence enterprises is also on the rise, but in the field of technology and application, there are challenges and risks of varying degrees. According to data from iiMedia Research, Chinese Internet users to try the will of the artificial intelligence technology is higher, but there are still 64.1% of Chinese Internet users think that there are risks of artificial intelligence, 40.3% of Internet users think the biggest hazards posed by artificial intelligence is a personal information leakage, 63.0% of netizens think that artificial intelligence technology has threat to humans, 38.6% of Internet users think that big data is the main cause of a threat to human development. For the development of artificial intelligence technology in the future, although the situation is all the way high, but still can not relax vigilance. A new round of industrial revolution brought by artificial intelligence has come, and the imbalance between education and technological development will inevitably lead to the emergence of unemployment. For the new demand brought by artificial intelligence, only keep learning can not be ahead of technology.

本报告研究涉及企业/品牌包括:新氧、更美、悦美、美黛拉、美丽神器、美呗、南方医院、伊美尔、熙朵、碧莲盛、雍禾植发、科发源植发、新生植发、恒博医疗、昊海生物科技、华熙生物、复星医药、深圳鹏爱医疗美容医院、北京丽都医疗美容医院

中国医疗美容行业处于快速发展期，iiMedia Research（艾媒咨询）监测发现，2018年中国医美行业市场规模达2245亿元，牙齿美容及面部美容是医美市场的重要构成部分，占比分别达32.5%和35.3%。目前中国医美行业已形成生产商、医美机构、终端市场三大产业链环节，产业发展前景广阔，但作为新兴行业，中国医疗美容行业将面临着行业监管、公共关系危机、行业竞争激烈等几大风险。

Driven by the rise of the younger generation of consumer groups and the development of new models in the medical beauty industry, the penetration rate and consumer demand of China's medical beauty industry continue to rise. In 2018, the penetration rate of Chinese medical users reached 7.4%, and women were the main medical and aesthetic consumers. The proportion is 88.9%. At present, there are more than 10,000 registered medical and beauty institutions in China, and the industry is in a period of rapid development. iiMedia Research found that embedding, double eyelids, and full body fat filling are the favorite surgical items for Chinese women and medical consumers, while nasal synthesis, tautological fat, cheeks, hair transplants, etc. For the Chinese male medical beauty consumer's favorite surgical project, potential customers in China's medical beauty industry are most concerned about the safety of surgery, followed by medical qualifications and word of mouth and surgery prices. Medical beauty as an emerging industry, public relations crisis, strict industry supervision, lack of relevant professionals is a factor that restricts its development, and in the future, with the influx of capital from the industry, the competition in China's medical and aesthetic industry will become more intense.

　iiMedia Research(艾媒咨询)数据显示，预计2016年中国“互联网+”传统文化应用用户规模将达到1.96亿人，增长率为56.8%。艾媒咨询分析师认为，互联网为传统文化市场注入活力。